J9023 – Injection, avelumab, 10 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9023
- Long description
- Injection, avelumab, 10 mg
- Short description
- Injection, avelumab, 10 mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- January 1, 2018
- Last change
- January 1, 2018 – No change
Frequently asked questions
What is HCPCS code J9023?
J9023 is a HCPCS Level II code for injection, avelumab, 10 mg.
Does Medicare cover J9023?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9010 – Injection, alemtuzumab, 10 mg
- J9011 – Injection, datopotamab deruxtecan-dlnk, 1 mg
- J9015 – Injection, aldesleukin, per single use vial
- J9017 – Injection, arsenic trioxide, 1 mg
- J9019 – Injection, asparaginase (erwinaze), 1,000 iu
- J9020 – Injection, asparaginase, not otherwise specified, 10,000 units
- J9021 – Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9022 – Injection, atezolizumab, 10 mg
- J9024 – Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
- J9025 – Injection, azacitidine, 1 mg
- J9026 – Injection, tarlatamab-dlle, 1 mg
- J9027 – Injection, clofarabine, 1 mg
- J9028 – Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
- J9029 – Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose
- J9030 – Bcg live intravesical instillation, 1 mg
- J9031 – Bcg (intravesical) per instillation
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.